Michael J. Fox Foundation Renames Parkinson's Study to Focus on Precision Medicine
The Michael J. Fox Foundation has transformed its Parkinson's Progression Markers Initiative into the Parkinson's Precision Medicine Initiative. The new effort concentrates on developing treatments tailored to each patient's individual biological differences. It has enrolled more than 4,200 clinical participants and over 47,000 online contributors. The initiative also seeks to redesign clinical trials so that therapies match specific patient profiles.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.


Discussion (0)
Log in to join the discussion and vote.
Log in